While the original 2002 paper in the Journal of Cosmetic Dermatology is referenced throughout current dermatology literature (including Pickart & Margolina, 2018), direct access is available through Wiley Online Library
Looking for the next step in obesity pharmacotherapies, the concept of combining entero-pancreatic hormones for obesity treatment was supported by the marked WL, sustained weight maintenance, and metabolic benefits observed with BS, which increase multiple gut hormone levels [9,10,11,12,13,14]
GHRPs stimulate growth hormone release by acting on different receptors in the pituitary
They are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
In keloids, it disrupts the FOXO4-p53 interaction, inducing apoptosis in senescent fibroblasts and reducing pro-inflammatory and mesenchymal fibroblast subpopulations